$TERN Terns Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Terns Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Terns Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Terns Pharmaceuticals, Inc. for free.

CIK Number: 0001831363
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TERN
Company Address: 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY 94404
Phone number: 650-525-5535 EXT

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong and is headquartered in Foster City, CA.

Terns Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
GORDON CARL LDirector1,326,4810shares bought: 3,791,204 / shares sold: 0 STRONG BUYFeb 26 20213 months ago

View all Terns Pharmaceuticals, Inc. insiders.

Terns Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 26 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorOption ExerciseA22.0625,000551,50025,000
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorOption ExerciseC0.00918,29500
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorOption ExerciseC0.00612,19600
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorOption ExerciseC0.001,071,42800
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorOption ExerciseC0.00714,28500
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorBuyP17.00285,0004,845,0002,274,7232 M to 2.3 M (+14.32 %)
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorBuyP17.00190,0003,230,0001,516,4811.3 M to 1.5 M (+14.32 %)
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorBuyC0.001,989,72301,989,7230 to 2 M
Feb 09 2021TERNTerns Pharmaceutic ...GORDON CARL LDirectorBuyC0.001,326,48101,326,4810 to 1.3 M
Feb 09 2021TERNTerns Pharmaceutic ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00918,29500
Feb 09 2021TERNTerns Pharmaceutic ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00612,19600
Feb 09 2021TERNTerns Pharmaceutic ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,071,42800
Feb 09 2021TERNTerns Pharmaceutic ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00714,28500
Feb 09 2021TERNTerns Pharmaceutic ...ORBIMED ADVISORS LLCDirectorBuyP17.00285,0004,845,0002,274,7232 M to 2.3 M (+14.32 %)
Feb 09 2021TERNTerns Pharmaceutic ...ORBIMED ADVISORS LLCDirectorBuyP17.00190,0003,230,0001,516,4811.3 M to 1.5 M (+14.32 %)

View all Terns Pharmaceuticals, Inc. insider transactions.